In addition, to be certain that any depression found at baseline was not the result of subtle symptomatology that distressed the individual but was not recognized or reported, the first 2 1/2 years of data were excluded from the analysis. As a result, the cardiac disease and deaths that occurred over the last 11 years could unequivocally be attributed to preexisting depression. When Inhibitors,research,lifescience,medical Wulsin published his meta-analysis 10 years later, all 10 studies that were included controlled in one way or another for baseline Trichostatin A nmr medical illness. The other evidence indicating that pre-existing heart disease is not the major cause of the association between depression and

heart disease comes from the SADHART Inhibitors,research,lifescience,medical study. When we initially planned that study, our expectation was that many of the cases of major depression that are observed in the intensive care or step-down units after hospitalization for MI would be mild and of very short duration. That was

our expectation, because we felt that an MI causes both severe psychological and physiological stress, and it would not be surprising that in vulnerable people, it could produce depression.51 Our expectation that many cases of post-MI depression would be mild was confirmed, but the idea that they would for the most part begin in the hospital after the coronary Inhibitors,research,lifescience,medical Inhibitors,research,lifescience,medical event and be of short duration was not correct. Fifty-three percent of the cases began before

hospitalization. Coronary events, either MI or unstable angina, are acute events. Ninety percent of patients hospitalized for MI are hospitalized within the first 24 hours. Ninety-three percent of the depressions that began before Inhibitors,research,lifescience,medical hospitalization began more than a month before hospitalization, and that is probably an underestimate of how many depressions actually began before the coronary event. SADHART was a clinical trial that randomized patients to sertraline or placebo, not an epidemiological study. It would not be considered ethical to recruit post-MI patients who were already being treated with antidepressant drugs into the trial. This would mean taking someone who was on antidepressant medication, stopping their medication, and randomizing them potentially to a placebo. Dichloromethane dehalogenase About 20% of patients who met the criteria for major depression were already receiving an antidepressant drug. As a result, probably closer to 70% of the patients observed to be depressed following their MI in the SADHART study actually had that depression prior to the coronary event. For these patients, the depression may have contributed to the coronary event, but the coronary event did not precipitate the depression. There was a similar incidence of MDD cases beginning before hospitalization in the ENRICHD trial (Carney, personal communication).